Home › Research › Disparities
Antihypertensive medication adherence in the Department of Veterans Affairs
Siegel D, Lopez J, Meier J.. The American journal of medicine, 2007-01-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Purpose Adherence measures the extent to which patients take medications as prescribed by their health care provider. The control of hypertension is dependent on medication adherence and may vary on the basis of antihypertensive medication class and other factors. Methods The Department of Veterans Affairs' automated pharmacy database captures pharmacy medication use; International Classification of Diseases, 9th Revision, diagnostic codes; and laboratory and patient demographic data on a monthly basis. Hypertensive patients who used thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel antagonists, and alpha-blockers from July 2002 to December 2003 were studied. The first date of prescription filling for each patient within the date range was the index date from which fill and refill dates were collected for up to 18 months to calculate medication possession ratios and days out of medication ratios. Patients were categorized as adherent if the medication possession ratio was 80% or greater. Logistic regression was used to study the association of medication class, age, gender, ethnicity, Veterans Affairs facility, and co-diagnosis with diabetes, schizophrenia/psychosis, depression, and dementia with medication adherence. Results We studied 40,492 hypertensive patients taking at least one antihypertensive drug class. The average age per class ranged from 67.4 to 72.9 years; 96% were male; and 51% were white, 8% were African-American, 4% were Asian-American, and 3% were Hispanic. Unadjusted adherence rates based on the medication possession ratio ranged from 78.3% for thiazide diuretics to 83.6% for angiotensin receptor blockers (P Conclusions Adherence rates with all antihypertensive medications were high. Although there were statistical differences by drug class, these differences were small. Ethnicity and depression identified groups that might benefit from programs to improve adherence.
What this study adds
Evidence grade: Low
The record lists 40,492 participants. This study examined adherence to antihypertensive medications among veterans and included dementia as one co-diagnosis among several factors. Reported effect size: 78.3%; 83.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Siegel, D., Lopez, J., & Meier, J. (2007). Antihypertensive medication adherence in the Department of Veterans Affairs. The American journal of medicine. https://doi.org/10.1016/j.amjmed.2006.06.028
Vancouver
Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. The American journal of medicine. 2007. doi:10.1016/j.amjmed.2006.06.028. PMID: 17208076.
BibTeX
@article{siegel2007-17208076,
author = {Siegel, D. and Lopez, J. and Meier, J.},
title = {{Antihypertensive medication adherence in the Department of Veterans Affairs}},
journal = {The American journal of medicine},
year = {2007},
doi = {10.1016/j.amjmed.2006.06.028},
pmid = {17208076},
url = {https://doi.org/10.1016/j.amjmed.2006.06.028}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results We studied 40,492 hypertensive patients taking at least one antihypertensive drug class.
Why it matters
This study examined adherence to antihypertensive medications among veterans and included dementia as one co-diagnosis among several factors. It concerns blood pressure medication adherence, not the treatment, cure or prevention of Alzheimer's disease.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Participants40,492
- Effect size78.3%; 83.6%
- Evidence strengthLow
How this study scored 53/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The American journal of medicine) |
| Journal's citation record | 3 / 4 | The American Journal of Medicine: journal h-index 386 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2007 — within 20 year(s) of the newest study here |
| Sample size | 4 / 4 | 40,492 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 227 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.8 citations a year over 21 year(s) since 2007 |
| Impact for its field and year | 4 / 6 | Cited 14.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 33 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Joy L. Meier: h-index 11 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 17208076) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Disparities from nearby years
Also in Disparities
98 studies in the library are filed under Disparities with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Disparities hub.